710 related articles for article (PubMed ID: 26940728)
1. A pilot study to compare the detection of HPV-16 biomarkers in salivary oral rinses with tumour p16(INK4a) expression in head and neck squamous cell carcinoma patients.
Chai RC; Lim Y; Frazer IH; Wan Y; Perry C; Jones L; Lambie D; Punyadeera C
BMC Cancer; 2016 Mar; 16():178. PubMed ID: 26940728
[TBL] [Abstract][Full Text] [Related]
2. A comprehensive evaluation of human papillomavirus positive status and p16INK4a overexpression as a prognostic biomarker in head and neck squamous cell carcinoma.
Deng Z; Hasegawa M; Aoki K; Matayoshi S; Kiyuna A; Yamashita Y; Uehara T; Agena S; Maeda H; Xie M; Suzuki M
Int J Oncol; 2014 Jul; 45(1):67-76. PubMed ID: 24820457
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of cell cycle-associated proteins p16, pRB, cyclin D1 and p53 in resected oropharyngeal carcinoma.
Plath M; Broglie MA; Förbs D; Stoeckli SJ; Jochum W
J Otolaryngol Head Neck Surg; 2018 Sep; 47(1):53. PubMed ID: 30189895
[TBL] [Abstract][Full Text] [Related]
4. P16(INK4A) immunostaining is a strong indicator for high-risk-HPV-associated oropharyngeal carcinomas and dysplasias, but is unreliable to predict low-risk-HPV-infection in head and neck papillomas and laryngeal dysplasias.
Mooren JJ; Gültekin SE; Straetmans JM; Haesevoets A; Peutz-Kootstra CJ; Huebbers CU; Dienes HP; Wieland U; Ramaekers FC; Kremer B; Speel EJ; Klussmann JP
Int J Cancer; 2014 May; 134(9):2108-17. PubMed ID: 24127203
[TBL] [Abstract][Full Text] [Related]
5. Combination of p16(INK4a) /Ki67 immunocytology and HPV polymerase chain reaction for the noninvasive analysis of HPV involvement in head and neck cancer.
Linxweiler M; Bochen F; Wemmert S; Lerner C; Hasenfus A; Bohle RM; Al-Kadah B; Takacs ZF; Smola S; Schick B
Cancer Cytopathol; 2015 Apr; 123(4):219-29. PubMed ID: 25557267
[TBL] [Abstract][Full Text] [Related]
6. The role of histologic subtype, p16(INK4a) expression, and presence of human papillomavirus DNA in penile squamous cell carcinoma.
Steinestel J; Al Ghazal A; Arndt A; Schnoeller TJ; Schrader AJ; Moeller P; Steinestel K
BMC Cancer; 2015 Apr; 15():220. PubMed ID: 25885064
[TBL] [Abstract][Full Text] [Related]
7. p16(INK4a) /Ki-67 co-expression specifically identifies transformed cells in the head and neck region.
Prigge ES; Toth C; Dyckhoff G; Wagner S; Müller F; Wittekindt C; Freier K; Plinkert P; Hoffmann J; Vinokurova S; Klussmann JP; von Knebel Doeberitz M; Reuschenbach M
Int J Cancer; 2015 Apr; 136(7):1589-99. PubMed ID: 25104331
[TBL] [Abstract][Full Text] [Related]
8. Impact of HPV infection on oral squamous cell carcinoma.
Götz C; Drecoll E; Straub M; Bissinger O; Wolff KD; Kolk A
Oncotarget; 2016 Nov; 7(47):76704-76712. PubMed ID: 27732948
[TBL] [Abstract][Full Text] [Related]
9. Frequency and prognostic significance of p16(INK4A) protein overexpression and transcriptionally active human papillomavirus infection in laryngeal squamous cell carcinoma.
Young RJ; Urban D; Angel C; Corry J; Lyons B; Vallance N; Kleid S; Iseli TA; Solomon B; Rischin D
Br J Cancer; 2015 Mar; 112(6):1098-104. PubMed ID: 25688737
[TBL] [Abstract][Full Text] [Related]
10. Human papillomavirus status in young patients with head and neck squamous cell carcinoma.
van Monsjou HS; van Velthuysen ML; van den Brekel MW; Jordanova ES; Melief CJ; Balm AJ
Int J Cancer; 2012 Apr; 130(8):1806-12. PubMed ID: 21607949
[TBL] [Abstract][Full Text] [Related]
11. Human papillomavirus status and p16(INK4A) expression in patients with mucosal squamous cell carcinoma of the head and neck in Queensland, Australia.
Antonsson A; Neale RE; Boros S; Lampe G; Coman WB; Pryor DI; Porceddu SV; Whiteman DC
Cancer Epidemiol; 2015 Apr; 39(2):174-81. PubMed ID: 25677091
[TBL] [Abstract][Full Text] [Related]
12. High-risk HPV DNA status and p16 (INK4a) expression as prognostic markers in patients with squamous cell cancer of oral cavity and oropharynx.
Śnietura M; Jaworska M; Pigłowski W; Goraj-Zając A; Woźniak G; Lange D
Pol J Pathol; 2010; 61(3):133-9. PubMed ID: 21225495
[TBL] [Abstract][Full Text] [Related]
13. HPV DNA in saliva from patients with SCC of the head and neck is specific for p16-positive oropharyngeal tumours.
Wasserman JK; Rourke R; Purgina B; Caulley L; Dimitroulakos J; Corsten M; Johnson-Obaseki S
J Otolaryngol Head Neck Surg; 2017 Jan; 46(1):3. PubMed ID: 28061890
[TBL] [Abstract][Full Text] [Related]
14. No evidence of oncogenic KRAS mutations in squamous cell carcinomas of the anogenital tract and head and neck region independent of human papillomavirus and p16(INK4a) status.
Prigge ES; Urban K; Stiegler S; Müller M; Kloor M; Mai S; Ottstadt M; Lohr F; Wenz F; Wagner S; Wittekindt C; Klussmann JP; Hampl M; von Knebel Doeberitz M; Reuschenbach M
Hum Pathol; 2014 Nov; 45(11):2347-54. PubMed ID: 25257576
[TBL] [Abstract][Full Text] [Related]
15. Low prevalence of transcriptionally active human papilloma virus in Indian patients with HNSCC and leukoplakia.
Bhosale PG; Pandey M; Desai RS; Patil A; Kane S; Prabhash K; Mahimkar MB
Oral Surg Oral Med Oral Pathol Oral Radiol; 2016 Nov; 122(5):609-618.e7. PubMed ID: 27765330
[TBL] [Abstract][Full Text] [Related]
16. HPV DNA, E6*I-mRNA expression and p16INK4A immunohistochemistry in head and neck cancer - how valid is p16INK4A as surrogate marker?
Hoffmann M; Tribius S; Quabius ES; Henry H; Pfannenschmidt S; Burkhardt C; Görögh T; Halec G; Hoffmann AS; Kahn T; Röcken C; Haag J; Waterboer T; Schmitt M
Cancer Lett; 2012 Oct; 323(1):88-96. PubMed ID: 22484467
[TBL] [Abstract][Full Text] [Related]
17. Performance of a Branch Chain RNA In Situ Hybridization Assay for the Detection of High-risk Human Papillomavirus in Head and Neck Squamous Cell Carcinoma.
Kerr DA; Arora KS; Mahadevan KK; Hornick JL; Krane JF; Rivera MN; Ting DT; Deshpande V; Faquin WC
Am J Surg Pathol; 2015 Dec; 39(12):1643-52. PubMed ID: 26426378
[TBL] [Abstract][Full Text] [Related]
18. P16(INK⁴a) overexpression is associated with CDKN2A mutation and worse prognosis in HPV-negative laryngeal squamous cell carcinomas.
Larque AB; Conde L; Hakim S; Alos L; Jares P; Vilaseca I; Cardesa A; Nadal A
Virchows Arch; 2015 Apr; 466(4):375-82. PubMed ID: 25652585
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic accuracy of p16
Prigge ES; Arbyn M; von Knebel Doeberitz M; Reuschenbach M
Int J Cancer; 2017 Mar; 140(5):1186-1198. PubMed ID: 27859245
[TBL] [Abstract][Full Text] [Related]
20. Combined P16 and human papillomavirus testing predicts head and neck cancer survival.
Salazar CR; Anayannis N; Smith RV; Wang Y; Haigentz M; Garg M; Schiff BA; Kawachi N; Elman J; Belbin TJ; Prystowsky MB; Burk RD; Schlecht NF
Int J Cancer; 2014 Nov; 135(10):2404-12. PubMed ID: 24706381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
